Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > Ronnie Miller: Now optimized with transformational products

View:

Post by prophetoffactz on Jun 04, 2024 12:53pm

Ronnie Miller: Now optimized with transformational products

Ronald W. Miller, Chair of the Company. “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.”

Comment

Comment by prophetoffactz on Jun 04, 2024 1:29pm

Claiming that AEZS is now optimized with transformational products is a big, big potential claim for a company trading approximately at the value of its cash targeting the markets AEZS is with the current market cap of AEZS. Ronnie Miller was trained in excellence at the world's largest biotech and should have an idea what is needed for transformational products. H.C. Wainwright's C$100 ...more

Comment

COSCIENS Biopharma Inc